Hormonal replacement therapy and obesity

Tomasz Paszkowski; Monika Kłodnicka

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2007
vol. 6

Send email

Copy url:

abstract:

Hormonal replacement therapy and obesity

Tomasz Paszkowski

,

Monika Kłodnicka

Przegląd Menopauzalny 2007; 2: 106–109

Online publish date: 2007/04/25

View full text Get citation

Obesity constitutes one of the most common disorders in the perimenopausal period – it concerns approximately 65% of women in this period of life. Hormone replacement therapy (HRT) does not induce the obesity. The excessive BMI is not an absolute contraindication for HRT; however, hormone therapy should be applied with extreme caution in obese women. The available literature indicates that in peri- and postmenopausal women with indications for the HRT, for safety reasons, the choice of the route of administration and the application of minimally effective dose are crucial.

keywords:

Hormonal replacement therapy and obesity

Tomasz Paszkowski , Monika Kłodnicka

menopause, hormone replacement therapy, obesity

Tomasz Paszkowski

,

Monika Kłodnicka